PortalPublikationenIvabradine in combination with beta-blocker therapy for the ...

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

Standard

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. / Köster, Ralf; Kähler, Jan; Ebelt, Henning; Soeffker, Gerold; Werdan, Karl; Meinertz, Thomas.

in: CLIN RES CARDIOL, Jahrgang 99, Nr. 10, 10, 2010, S. 665-672.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Köster, R, Kähler, J, Ebelt, H, Soeffker, G, Werdan, K & Meinertz, T 2010, 'Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.', CLIN RES CARDIOL, Jg. 99, Nr. 10, 10, S. 665-672. <http://www.ncbi.nlm.nih.gov/pubmed/20454968?dopt=Citation>

APA

Köster, R., Kähler, J., Ebelt, H., Soeffker, G., Werdan, K., & Meinertz, T. (2010). Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. CLIN RES CARDIOL, 99(10), 665-672. [10]. http://www.ncbi.nlm.nih.gov/pubmed/20454968?dopt=Citation

Vancouver

Köster R, Kähler J, Ebelt H, Soeffker G, Werdan K, Meinertz T. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. CLIN RES CARDIOL. 2010;99(10):665-672. 10.

Bibtex

@article{0edeb0cf7f334b6597f863f19c0ed9af,
title = "Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.",
abstract = "The anti-anginal efficacy of the selective I(f) inhibitor ivabradine has been demonstrated in controlled clinical trials. However, there is limited information about the safety and efficacy of a combined treatment of ivabradine with beta-blockers, particularly outside of clinical trials in every day practice. This analysis from the REDUCTION study evaluated the safety and efficacy of a combined therapy of beta-blockers and ivabradine in every day practice.",
author = "Ralf K{\"o}ster and Jan K{\"a}hler and Henning Ebelt and Gerold Soeffker and Karl Werdan and Thomas Meinertz",
year = "2010",
language = "Deutsch",
volume = "99",
pages = "665--672",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "10",

}

RIS

TY - JOUR

T1 - Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

AU - Köster, Ralf

AU - Kähler, Jan

AU - Ebelt, Henning

AU - Soeffker, Gerold

AU - Werdan, Karl

AU - Meinertz, Thomas

PY - 2010

Y1 - 2010

N2 - The anti-anginal efficacy of the selective I(f) inhibitor ivabradine has been demonstrated in controlled clinical trials. However, there is limited information about the safety and efficacy of a combined treatment of ivabradine with beta-blockers, particularly outside of clinical trials in every day practice. This analysis from the REDUCTION study evaluated the safety and efficacy of a combined therapy of beta-blockers and ivabradine in every day practice.

AB - The anti-anginal efficacy of the selective I(f) inhibitor ivabradine has been demonstrated in controlled clinical trials. However, there is limited information about the safety and efficacy of a combined treatment of ivabradine with beta-blockers, particularly outside of clinical trials in every day practice. This analysis from the REDUCTION study evaluated the safety and efficacy of a combined therapy of beta-blockers and ivabradine in every day practice.

M3 - SCORING: Zeitschriftenaufsatz

VL - 99

SP - 665

EP - 672

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 10

M1 - 10

ER -